Immunosuppressive strategies in renal transplantation at the beginning of the third millennium.
Abramowicz
D
D
Université Libre de Bruxelles, Belgium.
Wissing
K M
KM
Broeders
N
N
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D065095:Calcineurin Inhibitors; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods* / Q000639:trends*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use
D000961:Antilymphocyte Serum; D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus